1. [Chronic hepatitis B, hemosiderosis, and hepatic fibrosis in a renal graft recipient].
- Author
-
Zubkin ML, Pavlov ChS, Chervinko VI, Semenenko TA, Balakirev EM, Zolotarevskiĭ VB, Frolov AV, Baranova FS, Repetiĭ NG, Bakulin IG, Stanke AA, and Novozhenov VG
- Subjects
- Antiviral Agents therapeutic use, Biopsy, Diagnosis, Differential, Female, Follow-Up Studies, Hemosiderosis diagnosis, Hemosiderosis therapy, Hepatitis B, Chronic diagnosis, Hepatitis B, Chronic therapy, Humans, Liver Cirrhosis diagnosis, Liver Cirrhosis therapy, Middle Aged, Phlebotomy methods, Prognosis, Hemosiderosis etiology, Hepatitis B, Chronic etiology, Kidney Failure, Chronic surgery, Kidney Transplantation adverse effects, Liver Cirrhosis etiology
- Abstract
Chronic hepatitis B is a frequent concomitant disease in recipients of a renal graft that worsens results of kidney transplantation due to renal and extrarenal complications. Much rarer hemochromatosis either has genetic roots (hereditary hemochromatosis) or results from multiple blood transfusions and hemolysis during treatment by hemodialysis (secondary hemochromatosis). Combination of chronic hepatitis B and hemochromatosis increases the risk of chronic liver disease leading to cirrhosis and hepatocellular carcinoma. Success of antiviral therapy combined with massive phlebotomy is illustrated by a case of kidney transplantation to a patient with chronic hepatitis B of large duration and iron overload syndrome.
- Published
- 2009